Loading...

B. Joseph Guglielmo, PharmD

Title(s)Dean, School of Pharmacy, Dean's Office
SchoolSchool of Pharmacy
Address513 Parnassus Ave, MSB
San Francisco CA 94117
Phone415-476-8010
vCardDownload vCard
    Other Positions
    Title(s)Professor of Clinical Pharmacy


    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency 1979School of Pharmacy - Pharmacy Practice
    University of Southern California (USC)PharmD1978Pharmacy
    Santa Clara UniversityB.S.1973Biology
    Collapse Awards and Honors
    UCSF1981Long Foundation Award for Excellence in Teaching
    UCSF1981Pharmacy Residents Preceptorship Award
    UCSF1985Pharmacy Residents Preceptorship Award
    UCSF1986Long Foundation Award for Excellence in Teaching
    UCSF1987Pharmacy Residents Preceptorship Award
    UCSF1989Pharmacy Residents Preceptorship Award
    UCSF1988Pharmacy Residents Preceptorship Award
    UCSF1992Academic Senate Distinction in Teaching Award
    UCSF1992Commencement Speaker, School of Pharmacy
    California Society of Health-System Pharmacists1993Fellow
    Phi Lambda Sigma1995Pharmacy Leadership Society Recognition
    UCSF1995Pharmacy Residents Preceptorship Award
    UCSF1999Long Prize for Excellence in Teaching
    UCSF2005Vincent G. Pons Award in Clinical Infectious Diseases
    UCSF2010Faculty Mentoring Program Lifetime Achievement in Mentoring Award
    American College of Clinical Pharmacy2011Fellow
    UCSF2013Troy C. Daniels Distinguished Professorship in Pharmaceutical Science
    Infectious Diseases Society America2013Fellow

    Collapse Overview 
    Collapse Overview
    B. Joseph Guglielmo, PharmD, is a pharmacist, clinical scientist, teacher, and international expert in the evidence-based use of antimicrobials to treat infections.

    He was named dean of the UCSF School of Pharmacy in 2012 and holds the Troy C. Daniels Distinguished Professorship in Pharmaceutical Science.

    As dean, Guglielmo oversees the activities and progress of three departments; a campus organized research unit; and a dean’s office charged with School administration and finance, strategic planning, communications, academic affairs, and the development and delivery of a doctor of pharmacy (PharmD) degree program. His leadership as dean actively supports the distinguishing UCSF concept of One UCSF and upholds the institution’s PRIDE values.

    During his tenure as dean, the School of Pharmacy has remained the top recipient among pharmacy schools nationwide of research dollars from the National Institutes of Health (NIH), and its PharmD degree program has remained among the top-rated such programs in the nation.

    Guglielmo initiated a transformation of the PharmD degree program, which welcomed its first class in 2018. The program’s foundation of scientific thinking evolves from the distinctive scientific mindset of the faculty, and the faculty’s drive to seek and apply new knowledge across research, education, and patient care.

    Guglielmo is widely known as an advocate for therapeutics-related research, from basic science to health policy research. As chair of the School's Department of Clinical Pharmacy, Guglielmo oversaw a 40 percent increase in the Department of Clinical Pharmacy’s faculty research funding. He created the department-run Medication Outcomes Center in 2007 to improve medication use at UCSF Health and beyond. In the late 1980s he developed the UCSF Medical Center Antimicrobial Stewardship Program to ensure the safe, effective use of antimicrobials, focusing upon decreasing antimicrobial resistance. The program was one of the earliest programs of its kind in the United States.

    As patients seek new and cost-effective health care with increasingly complicated disease states and medications, Guglielmo advocates for research on new ways for pharmacists to care for patients, especially in the community. He also supports strong relationships among clinical scientists and their upstream basic and translational scientist colleagues, as demonstrated through his own collaborations. Guglielmo has been actively involved in the UCSF Clinical and Translational Science Institute (CTSI) from its inception and during its renewal; he has also served as past associate director of the CTSI Mentor Development Program.

    His personal research agenda involves the safe, effective, and appropriate use of antimicrobials, as well as the pharmacoepidemiology and pharmacokinetics of anti-infective agents. He is the author of numerous peer-reviewed papers, book chapters, and abstracts, the majority related to anti-infective agents.

    He believes that the most important clinical research is shaped through the researcher’s own clinical experiences. Together with his administrative, research, and teaching responsibilities, he continues to be active as an infectious diseases pharmacist supporting the UCSF Medical Center Antimicrobial Stewardship Program and serving on the Infectious Diseases Consult Service team. These experiences continue to provide the background for important hypothesis-centered research on the safe, effective use of antimicrobials.

    Beyond the hospital, Guglielmo developed clinical pharmacy services for UCSF HIV/AIDS programs, specifically for the HIV Women's Program and the Men of Color Program.

    Guglielmo has taught doctor of pharmacy students, pharmacy residents and fellows, medical students and residents, and infectious diseases fellows for decades, and he has mentored infectious diseases specialty pharmacist residents and fellows continuously since 1986. He has also mentored a number of international scholars, including Fogarty fellows.

    He is the recipient of many teaching awards, including the UCSF Lifetime Achievement in Mentoring Award, Resident Preceptor of the Year Awards, UCSF School of Pharmacy Long Teaching Awards, and UCSF Academic Senate Distinction in Teaching Award. He is a fellow of the American College Clinical Pharmacy and the Infectious Diseases Society of America.


    Guglielmo earned a PharmD from the University of Southern California in 1978 and completed a PharmD residency at UCSF in 1979.

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Metronidazole neurotoxicity: suspicions confirmed. Clin Infect Dis. 2020 Apr 08. Guglielmo BJ. PMID: 32266372.
      View in: PubMed   Mentions:    Fields:    
    2. The Cost of Pharmaceutical Company Detailing Visits and Medication Samples. JAMA Intern Med. 2020 Jan 27. Guglielmo BJ. PMID: 31985770.
      View in: PubMed   Mentions:    Fields:    
    3. Medication-related problems during transfer from hospital to home care: baseline data from Switzerland. Int J Clin Pharm. 2018 Dec; 40(6):1614-1620. Meyer-Massetti C, Hofstetter V, Hedinger-Grogg B, Meier CR, Guglielmo BJ. PMID: 30291577.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. The scope of drug-related problems in the home care setting. Int J Clin Pharm. 2018 Apr; 40(2):325-334. Meyer-Massetti C, Meier CR, Guglielmo BJ. PMID: 29322475.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Incidence and risk factors for vancomycin nephrotoxicity in acutely ill pediatric patients. J Pharm Technol. 2018; 34:9-16. Woldu H, Guglielmo BJ..
    6. Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain. Parasitol Res. 2015 Dec; 114(12):4431-9. Roy SL, Atkins JT, Gennuso R, Kofos D, Sriram RR, Dorlo TP, Hayes T, Qvarnstrom Y, Kucerova Z, Guglielmo BJ, Visvesvara GS. PMID: 26329128.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    7. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012. JAMA Intern Med. 2014 Oct; 174(10):1704-5. Cheng CM, Shin J, Guglielmo BJ. PMID: 25127107.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Pediatric medication administration errors and workflow following implementation of a bar code medication administration system. J Healthc Qual. 2014 Jul-Aug; 36(4):54-61; quiz 61-3. Hardmeier A, Tsourounis C, Moore M, Abbott WE, Guglielmo BJ. PMID: 25041604.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort. Pharmacotherapy. 2014 Jul; 34(7):677-85. Gahbauer AM, Gonzales ML, Guglielmo BJ. PMID: 24753176.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. Ethanol locks in the prevention and treatment of catheter-related bloodstream infections. Ann Pharmacother. 2014 May; 48(5):607-15. Tan M, Lau J, Guglielmo BJ. PMID: 24554477.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    11. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections. Pediatr Infect Dis J. 2013 Oct; 32(10):1077-9. Frymoyer A, Guglielmo BJ, Hersh AL. PMID: 23652479.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    12. Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. J Perinatol. 2013 Oct; 33(10):778-82. Frymoyer A, Lee S, Bonifacio SL, Meng L, Lucas SS, Guglielmo BJ, Sun Y, Verotta D. PMID: 23702622.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. Co-administration of a commonly used Zimbabwean herbal treatment (African potato) does not alter the pharmacokinetics of lopinavir/ritonavir. Int J Infect Dis. 2013 Oct; 17(10):e857-61. Gwaza L, Aweeka F, Greenblatt R, Lizak P, Huang L, Guglielmo BJ. PMID: 23587599.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCTClinical Trials
    14. Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital. Hosp Pharm. 2013 Apr; 48(4):302-7. Burrell C, Tsourounis C, Quan D, Jue V, Tam E, Guglielmo BJ. PMID: 24421479.
      View in: PubMed   Mentions:
    15. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. Pharmacotherapy. 2013 Jul; 33(7):718-26. Frymoyer A, Meng L, Bonifacio SL, Verotta D, Guglielmo BJ. PMID: 23553582.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    16. The colchicine debacle. JAMA Intern Med. 2013 Feb 11; 173(3):184-5. Guglielmo BJ. PMID: 23277277.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc (2003). 2012 Sep-Oct; 52(5):e67-73. Cocohoba JM, Murphy P, Pietrandoni G, Guglielmo BJ. PMID: 23023860.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    18. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012 Sep; 26(9):526-31. Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. PMID: 22860900.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    19. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. Int J Clin Pharm. 2012 Apr; 34(2):282-5. Swartling M, Gupta R, Dudas V, Guglielmo BJ. PMID: 22331444.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    20. Boxed warning inconsistencies between drug information resources and the prescribing information. Am J Health Syst Pharm. 2011 Sep 01; 68(17):1626-31. Cheng CM, Fu C, Guglielmo BJ, Auerbach AD. PMID: 21856808.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy. 2011 Sep; 31(9):871-6. Frymoyer A, Guglielmo BJ, Wilson SD, Scarpace SB, Benet LZ, Hersh AL. PMID: 21923588.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    22. A critical appraisal of and recommendations for faculty development. Am J Pharm Educ. 2011 Aug 10; 75(6):122. Guglielmo BJ, Edwards DJ, Franks AS, Naughton CA, Schonder KS, Stamm PL, Thornton P, Popovich NG. PMID: 21931460.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    23. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case. Int J Clin Pharm. 2011 Oct; 33(5):806-14. Meyer-Massetti C, Vaerini S, Rätz Bravo AE, Meier CR, Guglielmo BJ. PMID: 21809143.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    24. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling". Arch Intern Med. 2011 May 23; 171(10):946-7. Cheng C, Guglielmo BJ. PMID: 21606102.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Systematic review of medication safety assessment methods. Am J Health Syst Pharm. 2011 Feb 01; 68(3):227-40. Meyer-Massetti C, Cheng CM, Schwappach DL, Paulsen L, Ide B, Meier CR, Guglielmo BJ. PMID: 21258028.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    26. Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients. Am J Infect Control. 2010 Nov; 38(9):706-10. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS. PMID: 20605267.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. National estimates and predictors of prescription medication sample use in the United States, 1999-2005. J Am Pharm Assoc (2003). 2010 Nov-Dec; 50(6):677-85. Macdougall C, Udkow T, Guglielmo BJ, Vittinghoff E, Martin J. PMID: 21071311.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. A prescription for improved chronic disease management: have community pharmacists function at the top of their training: comment on "Engaging physicians and pharmacists in providing smoking cessation counseling". Arch Intern Med. 2010 Oct 11; 170(18):1646-7. Guglielmo BJ. PMID: 20937923.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Coverage of FDA medication boxed warnings in commonly used drug information resources. Arch Intern Med. 2010 May 10; 170(9):831-3. Cheng CM, Guglielmo BJ, Maselli J, Auerbach AD. PMID: 20458094.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? J Hosp Med. 2010 Apr; 5(4):E8-16. Meyer-Massetti C, Cheng CM, Sharpe BA, Meier CR, Guglielmo BJ. PMID: 20394022.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    31. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin Infect Dis. 2010 Apr 01; 50(7):e47-9. Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo BJ. PMID: 20192728.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    32. Development of daptomycin-susceptible, methicillin-resistant Staphylococcus aureus pneumonia during high-dose daptomycin therapy. Clin Infect Dis. 2009 Oct 15; 49(8):1286-7. Koplowicz YB, Schwartz BS, Guglielmo BJ. PMID: 19780665.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    33. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2010 Feb; 12(1):45-50. Martin T, Sharma M, Damon L, Kaplan L, Guglielmo BJ, Working M, O'Malley R, Hwang J, Linker C. PMID: 19793068.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    34. Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. Clin Transl Sci. 2009 Jun; 2(3):216-21. Feldman MD, Huang L, Guglielmo BJ, Jordan R, Kahn J, Creasman JM, Wiener-Kronish JP, Lee KA, Tehrani A, Yaffe K, Brown JS. PMID: 19774102.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    35. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009 May; 28(5):398-402. Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. PMID: 19295465.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    36. Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures. Ann Pharmacother. 2009 Jan; 43(1):28-35. Yang K, Zhuo H, Guglielmo BJ, Wiener-Kronish J. PMID: 19033484.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    37. Five years later: re-examining the financial burden of boosting with Norvir. AIDS. 2008 Nov 12; 22(17):2402-4. Marquez C, Guglielmo BJ, Klausner JD. PMID: 18981784.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Antimicrobial stewardship programs: interventions and associated outcomes. Expert Rev Anti Infect Ther. 2008 Apr; 6(2):209-22. Patel D, Lawson W, Guglielmo BJ. PMID: 18380603.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    39. Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. Cerebrovasc Dis. 2008; 25(1-2):157-63. Frenzel T, Lee CZ, Kim H, Quinnine NJ, Hashimoto T, Lawton MT, Guglielmo BJ, McCulloch CE, Young WL. PMID: 18212521.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    40. Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding? Ann Pharmacother. 2008 Feb; 42(2):289-90. Schwartz BS, Ngo PD, Guglielmo BJ. PMID: 18172014.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    41. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. J Am Pharm Assoc (2003). 2007 Sep-Oct; 47(5):613-5. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ. PMID: 17848351.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. Ann Pharmacother. 2007 Sep; 41(9):1427-35. Yang K, Guglielmo BJ. PMID: 17666573.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    43. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study. BMC Infect Dis. 2007 Jul 02; 7:70. Riedel A, Choe L, Inciardi J, Yuen C, Martin T, Guglielmo BJ. PMID: 17605773.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4. J Herb Pharmacother. 2007; 7(1):39-56. Nicandro JP, Tsourounis C, Frassetto L, Guglielmo BJ. PMID: 17594986.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein. Drug Metab Dispos. 2006 Jul; 34(7):1136-44. Huang Y, Okochi H, May BC, Legname G, Prusiner SB, Benet LZ, Guglielmo BJ, Lin ET. PMID: 16581945.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    46. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol. 2006 Mar-Apr; 53(2):121-6. Schuster FL, Guglielmo BJ, Visvesvara GS. PMID: 16579814.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimals
    47. Pharmacological advances in the treatment of invasive candidiasis. Expert Rev Anti Infect Ther. 2006 Feb; 4(1):137-49. Deck DH, Guglielmo BJ. PMID: 16441215.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    48. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J Cereb Blood Flow Metab. 2006 Sep; 26(9):1157-64. Lee CZ, Yao JS, Huang Y, Zhai W, Liu W, Guglielmo BJ, Lin E, Yang GY, Young WL. PMID: 16395286.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    49. Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections. Pharmacotherapy. 2006 Jan; 26(1):61-7. Mendez MN, Gibbs L, Jacobs RA, McCulloch CE, Winston L, Guglielmo BJ. PMID: 16509027.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    50. Impact of a series of interventions in vancomycin prescribing on use and prevalence of vancomycin-resistant enterococci. Jt Comm J Qual Patient Saf. 2005 Aug; 31(8):469-75. Guglielmo BJ, Dudas V, Maewal I, Young R, Hilts A, Villmann M, Gibbs L, Gropper M, Jacobs R. PMID: 16156195.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    51. Antimicrobial drug prescribing for pneumonia in ambulatory care. Emerg Infect Dis. 2005 Mar; 11(3):380-4. MacDougall C, Guglielmo BJ, Maselli J, Gonzales R. PMID: 15757551.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    52. Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia. Pharmacotherapy. 2005 Jan; 25(1):59-66. Chang NN, Murray CK, Houck PM, Bratzler DW, Greenway C, Guglielmo BJ. PMID: 15767221.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    53. Pharmacokinetics of quinacrine in the treatment of prion disease. BMC Infect Dis. 2004 Nov 29; 4:53. Yung L, Huang Y, Lessard P, Legname G, Lin ET, Baldwin M, Prusiner SB, Ryou C, Guglielmo BJ. PMID: 15569390.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    54. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother. 2004 Jul-Aug; 38(7-8):1148-52. Killgore KM, March KL, Guglielmo BJ. PMID: 15150380.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    55. Pharmacokinetics of valaciclovir. J Antimicrob Chemother. 2004 Jun; 53(6):899-901. MacDougall C, Guglielmo BJ. PMID: 15140857.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    56. Compliance in two medical centers with criteria for use of caspofungin and lipid-based amphotericin B. Am J Health Syst Pharm. 2004 May 01; 61(9):915-20. Bower AN, Tang HM, Guglielmo BJ. PMID: 15156967.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. Impact of emerging technologies on medication errors and adverse drug events. Am J Health Syst Pharm. 2003 Jul 15; 60(14):1447-58. Oren E, Shaffer ER, Guglielmo BJ. PMID: 12892029.
      View in: PubMed   Mentions: 45     Fields:    
    58. Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. Antimicrob Agents Chemother. 2003 Jul; 47(7):2351-3. Phan DD, Chin-Hong P, Lin ET, Anderle P, Sadee W, Guglielmo BJ. PMID: 12821497.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    59. Pharmacy-based intervention to reduce antibiotic use for acute bronchitis. Ann Pharmacother. 2003 Feb; 37(2):187-91. Hickman DE, Stebbins MR, Hanak JR, Guglielmo BJ. PMID: 12549944.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    60. Characteristics of antimicrobial overrides associated with automated dispensing machines. Am J Health Syst Pharm. 2002 Aug 01; 59(15):1445-8. Oren E, Griffiths LP, Guglielmo BJ. PMID: 12166045.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. Patient education for H pylori: who benefits? West J Med. 2002 Mar; 176(2):97. Yang K, Guglielmo BJ. PMID: 11897729.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    62. Antimicrobial therapy of gram-negative bacteremia at two university-affiliated medical centers. Am J Med. 2002 Feb 15; 112(3):204-11. Graff LR, Franklin KK, Witt L, Cohen N, Jacobs RA, Tompkins L, Guglielmo BJ. PMID: 11893347.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    63. Restricted access to automated dispensing machines for surgical antimicrobial prophylaxis. Am J Health Syst Pharm. 2001 May 01; 58(9):797-9. Botwin KJ, Chan J, Jacobs R, Guglielmo BJ. PMID: 11351920.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    64. Impact of an intravenous fluconazole restriction policy on patient outcomes. Ann Pharmacother. 2001 Jan; 35(1):9-13. Burkiewicz JS, Kostiuk KA, Jacobs RA, Guglielmo BJ. PMID: 11197590.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother. 2000 Apr; 34(4):446-52. Dudas V, Hopefl A, Jacobs R, Guglielmo BJ. PMID: 10772428.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    66. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. Clin Infect Dis. 2000 Jan; 30(1):205-7. Guglielmo BJ, Luber AD, Paletta D, Jacobs RA. PMID: 10619757.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    67. Prevention of adverse events in hospitalized patients using an antimicrobial review program. West J Med. 1999 Sep; 171(3):159-62. Guglielmo BJ, Luber AD, Corelli RL, Flaherty JF, Jacobs RA. PMID: 10560287.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Risk factors for amphotericin B-induced nephrotoxicity. J Antimicrob Chemother. 1999 Feb; 43(2):267-71. Luber AD, Maa L, Lam M, Guglielmo BJ. PMID: 11252333.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    69. Use of antimicrobial agents in patients with cardiovascular disease. J Cardiovasc Nurs. 1999 Jan; 13(2):23-30. Guglielmo BJ. PMID: 9888061.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    70. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis. 1998 Sep; 27(3):603-18. Wong-Beringer A, Jacobs RA, Guglielmo BJ. PMID: 9770163.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    71. Pharmacokinetics and pharmacodynamics of ceftizoxime in abscess fluid. J Antimicrob Chemother. 1997 Mar; 39(3):437-8. Guglielmo BJ, Kostiuk KA, Pons VG. PMID: 9096200.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    72. Hypothermia following the intravenous administration of amphotericin B. Clin Infect Dis. 1996 Nov; 23(5):1187-8. Barlows TG, Luber AD, Jacobs RA, Guglielmo BJ. PMID: 8922832.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    73. Aerosolized amphotericin B in prophylaxis of pulmonary aspergillosis. Ann Pharmacother. 1996 Oct; 30(10):1175-6. Tsourounis C, Guglielmo BJ. PMID: 8893125.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin. Am J Health Syst Pharm. 1996 Sep 01; 53(17):2097-8. Guglielmo BJ, Jacobs RA. PMID: 8870902.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci. J Infect Dis. 1996 May; 173(5):1292-4. Luber AD, Jacobs RA, Jordan M, Guglielmo BJ. PMID: 8627091.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    76. Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients. J Antimicrob Chemother. 1996 May; 37(5):1040-2. Guglielmo BJ, Quan LA, Stulbarg MS. PMID: 8737161.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    77. Practical strategies for the appropriate use of antimicrobials. Pharm World Sci. 1995 Jul 28; 17(4):96-102. Guglielmo BJ. PMID: 7581222.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    78. Influence of timing of antibiotic administration on tissue concentrations during surgery. Am J Surg. 1995 Apr; 169(4):379-81. Wong-Beringer A, Corelli RL, Schrock TR, Guglielmo BJ. PMID: 7694975.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    79. Sterility of unit dose syringes of filgrastim and sargramostim. Am J Hosp Pharm. 1994 Nov 15; 51(22):2811-2. Singh RF, Corelli RL, Guglielmo BJ. PMID: 7531941.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    80. Penetration of fluconazole into abscess fluid. J Antimicrob Chemother. 1994 Oct; 34(4):603-5. Kostiuk KA, Pons VG, Guglielmo BJ. PMID: 7868415.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    81. Systemic absorption of oral fluconazole after gastrointestinal resection. J Antimicrob Chemother. 1994 May; 33(5):1070. Joe LA, Jacobs RA, Guglielmo BJ. PMID: 8089060.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    82. Immune globulin therapy in allogeneic bone marrow transplant: a critical review. Bone Marrow Transplant. 1994 May; 13(5):499-510. Guglielmo BJ, Wong-Beringer A, Linker CA. PMID: 8054903.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    83. The new macrolides. Azithromycin and clarithromycin. West J Med. 1994 Jan; 160(1):31-7. Kanatani MS, Guglielmo BJ. PMID: 8128699.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    84. Nosocomial funguria: resultant morbidity and therapeutic intervention. Clin Infect Dis. 1993 Dec; 17(6):1066-7. Wong-Beringer A, Jacobs RA, Guglielmo BJ. PMID: 8110936.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    85. Ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis: a randomized, prospective, blinded clinical study. Neurosurgery. 1993 Sep; 33(3):416-22; discussion 422-3. Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB. PMID: 8413872.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    86. Comment; ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis. Neurosurgery. 1993 Sep; 33(3):537. Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB. PMID: 8413895.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    87. Home antibiotic therapy for streptococcal endocarditis: a call for a controlled trial. Am J Med. 1993 Jan; 94(1):111-2. Colford JM, Corelli RL, Ganz JW, Guglielmo BJ, Jacobs RA. PMID: 8420289.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    88. Treatment of funguria. JAMA. 1992 May 27; 267(20):2780-5. Wong-Beringer A, Jacobs RA, Guglielmo BJ. PMID: 1578598.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    89. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Clin Pharm. 1992 Mar; 11(3):223-35. Barriere SL, Guglielmo BJ. PMID: 1611812.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    90. Medication usage patterns in patients with human immunodeficiency virus infection: a comparison of patient-reported medication usage with medical chart review. DICP. 1991 Dec; 25(12):1374-8. Corelli RL, Guglielmo BJ, Kapusnik-Uner JE, McMaster JR, Greenblatt RM. PMID: 1815436.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    91. Iodine toxicity secondary to continuous povidone-iodine mediastinal irrigation in dogs. J Surg Res. 1990 Nov; 49(5):428-34. Glick PL, Guglielmo BJ, Winter ME, Finkbeiner W, Turley K. PMID: 2246887.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    92. Antibiotic prophylaxis in cesarean section. DICP. 1990 Sep; 24(9):841-6. Glick M, Guglielmo BJ. PMID: 2260343.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. What is the clinical role of aerosolized ribavirin? DICP. 1990 Jul-Aug; 24(7-8):735-8. Hebert MF, Guglielmo BJ. PMID: 2197815.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    94. Antimicrobial therapy. Cost-benefit considerations. Drugs. 1989 Oct; 38(4):473-80. Guglielmo BJ, Brooks GF. PMID: 2510985.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    95. Experience with selective reporting of susceptibility to antimicrobial agents. Am J Hosp Pharm. 1989 Sep; 46(9):1816-8. Brodowy BA, Guglielmo BJ, York MK, Herfindal ET, Brooks GF. PMID: 2801717.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    96. Microbiology and antibiotics in infectious abdominal emergencies. Emerg Med Clin North Am. 1989 Aug; 7(3):611-29. Tam J, Guglielmo BJ. PMID: 2663459.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    97. Pharmacist-managed drug therapy in California hospitals. Am J Hosp Pharm. 1989 Jul; 46(7):1366-9. Guglielmo BJ, Schweigert BF, Kishi DT. PMID: 2757041.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    98. Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis. J Infect Dis. 1989 Jun; 159(6):1154-5. Oliva SL, Guglielmo BJ, Jacobs R, Pons VG. PMID: 2491408.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    99. Effect of surgical blood loss and volume replacement on antibiotic pharmacokinetics. Ann Thorac Surg. 1989 Jun; 47(6):857-9. Sue D, Salazar TA, Turley K, Guglielmo BJ. PMID: 2757440.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    100. The exposure of health care workers to ribavirin aerosol. JAMA. 1989 Apr 07; 261(13):1880-1. Guglielmo BJ, Jacobs RA, Locksley RM. PMID: 2926922.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    101. Altered pharmacokinetics of antibiotics during vascular surgery. Am J Surg. 1989 Apr; 157(4):410-2. Guglielmo BJ, Salazar TA, Rodondi LC, Carver M, Goldstone J, Stoney RJ. PMID: 2929864.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    102. Amphotericin B concentration in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis. Clin Pharm. 1989 Mar; 8(3):220-1. Dugoni BM, Guglielmo BJ, Hollander H. PMID: 2706895.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    103. Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens. Antimicrob Agents Chemother. 1988 Dec; 32(12):1825-9. Flaherty JF, Rodondi LC, Guglielmo BJ, Fleishaker JC, Townsend RJ, Gambertoglio JG. PMID: 3245695.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    104. Assessing Exposures of Health-care Personnel to Aerosols of Ribavirin-California. Morbidity and Mortality Weekly Reports. 1988; 37:560-562. R.J. Harrison, J. Bellows, D. Rempel, L. Rudolph, K. Kizer, A. Jin, B.J. Guglielmo..
    105. We are Concerned About Ribavirin Exposure. Resp. Care. 1988; 33:809-810. M.J. Mahlmeister, B.J. Guglielmo, and R. Harrison.
    106. Comparison of Antibiotic Activity Using Serum Bactericidal Activity Over Time. Antimicrob. Agents Chemother. 1988; 32:1511-1514. B.J. Guglielmo and L.C. Rodondi..
    107. Effect of Protein Binding on Serum Bactericidal Activities of Ceftazidime and Cefoperazone in Healthy Volunteers. Antimicrob. Agents Chemother9. Effect of Protein Binding on Serum Bactericidal Activities of Ceftazidime and Cefoperazone in Healthy Volunteers. 1988; 32:298-302. Y.W.F. Lam, M.H. Duroux, J.G. Gambertoglio, S.L. Barriere, and B.J. Guglielmo..
    108. Severe Hypersensitivity Reaction Upon Rechallenge With Trimethoprim-sulfamethoxazole in a Patient With AIDS. Drug Intell. Clin. Pharm. 22, 43-45 (1988). 1988; 22:43-45. P.A. Arnold, B.J. Guglielmo, and H. Hollander.
    109. Pharmacokinetics of Cefoperazone and Tobramycin Alone and in Combination. Antimicrob. Ag. Chemother. 1987; 31:264-266. B.J. Guglielmo, J.F. Flaherty, T.M. Woods, G. LaFollette, and J.G. Gambertoglio.
    110. Comparative Pharmacokinetics of Low- and High-Dose Ticarcillin. Antimicrob. Ag. Chemother. 1986; 30:359-360. B.J. Guglielmo, J.F. Flaherty, R. Batman, S.L. Barriere, and J.G. Gambertoglio.
    111. Iodine Toxicity in a Patient Treated by Continuous Povidone-Iodine Mediastinal Irrigation. Ann. Thorac. Surg. 1985; 478-480(39). P.L. Glick, B.J. Guglielmo, R.F. Tranbaugh, and K. Turley.
    112. Excessive Potassium Depletion with Metolazone and Furosemide. Clin. Pharm. 1983; 2:304. W.A. Kehoe and B.J. Guglielmo..
    113. Prolonged Diarrhea Secondary to Methyldopa Therapy. Drug Intell. Clin. Pharm. 1983; 17:462. B.D. Quart and B.J. Guglielmo..
    114. Antibiotic Prophylaxis in Surgical Procedures. A Critical Analysis of the Literature. Arch. Surg. 1983; 118:943-955. B.J. Guglielmo, D.C. Hohn, P.J. Koo, T.K. Hunt, R.C. Sweet, and J.E. Conte.
    115. Theophylline Elixir, Moxalactam, and a Disulfiram Reaction. Ann. Int. Med. 1982; 97:621-622. K.R. Brown, B.J. Guglielmo, V.G. Pons, and R.A. Jacobs.
    B. Joseph's Networks
    Concepts (465)
    Derived automatically from this person's publications.
    _
    Co-Authors (50)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _